TNFRSF18 and systemic lupus erythematosus: SLE patients with a percentage of CD4+CD25low/-GITR+ cells higher than 1.4% (90th percentile of the distribution in HCs) were defined as having an expansion of CD4+CD25low/-GITR+ cells (number 16; 50%).